Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

Roche - Basel

Roche moves eye drug lampalizumab into phase III

It could be the first treatment for geographic atrophy

Array appoints Victor Sandor chief medical officer

He joins from Incyte and will replace Michael Needle

- PMLiVE

NHS ‘not driving’ health innovation

Minister for Life Sciences acknowledges UK has more to do

- PMLiVE

Seven steps to innovating your digital strategy

Dealing with digitally native HCPs

- PMLiVE

UK pharmacists to have greater role in public health

Community pharmacies should be part of ‘primary care family’, says Kevin Fenton

- PMLiVE

Avastin safe in eye disease, says Cochrane

Recommends off-label use of Roche drug as cheaper alternative to Novartis’ Lucentis

- PMLiVE

Scottish independence ‘would weaken’ UK life sciences sector

Pharma leaders say Yes vote would hold industry back

EU flag

EC slammed for pharma oversight changes

Organisations criticise decision to transfer responsibility for pharma policy from health to industrial department

Eli Lilly HQ

Lilly closes in on another Cyramza indication

Could be used for colorectal cancer in addition to stomach cancer

European Commissioner for health and food safety elected

Vytenis Andriukaitis will take on the role from October

- PMLiVE

Adelphi Worldwide acquires The Planning Shop International

Deal with the international healthcare consultancy agency will extend portfolio

The genetic makeup of a pharma company

Thinking of your company’s DNA is much more than a figure of speech

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links